6B8U | pdb_00006b8u

Crystals Structure of B-Raf kinase domain in complex with an Imidazopyridinyl benzamide inhibitor


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.68 Å
  • R-Value Free: 
    0.218 (Depositor), 0.225 (DCC) 
  • R-Value Work: 
    0.178 (Depositor), 0.182 (DCC) 
  • R-Value Observed: 
    0.180 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 6B8U

Ligand Structure Quality Assessment 


This is version 1.2 of the entry. See complete history

Literature

Imidazo[1,2-a]pyridin-6-yl-benzamide analogs as potent RAF inhibitors.

Smith, A.Ni, Z.J.Poon, D.Huang, Z.Chen, Z.Zhang, Q.Tandeske, L.Merritt, H.Shoemaker, K.Chan, J.Kaufman, S.Huh, K.Murray, J.Appleton, B.A.Cowan-Jacob, S.W.Scheufler, C.Kanazawa, T.Jansen, J.M.Stuart, D.Shafer, C.M.

(2017) Bioorg Med Chem Lett 27: 5221-5224

  • DOI: https://doi.org/10.1016/j.bmcl.2017.10.047
  • Primary Citation Related Structures: 
    5MZ3, 6B8U

  • PubMed Abstract: 

    A series of imidazo[1,2-a]pyridin-6-yl-benzamide analogs was designed as inhibitors of B-RAF V600E . Medicinal chemistry techniques were employed to explore the SAR for this series and improve selectivity versus P38 and VEGFR2.


  • Organizational Affiliation
    • Global Discovery Chemistry/Oncology & Exploratory Chemistry, Novartis Institutes for Biomedical Research, 5300 Chiron Way, Emeryville, CA 94608, United States.

Macromolecule Content 

  • Total Structure Weight: 64.73 kDa 
  • Atom Count: 4,121 
  • Modeled Residue Count: 501 
  • Deposited Residue Count: 562 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Serine/threonine-protein kinase B-raf
A, B
281Homo sapiensMutation(s): 0 
Gene Names: BRAFBRAF1RAFB1
EC: 2.7.11.1
UniProt & NIH Common Fund Data Resources
Find proteins for P15056 (Homo sapiens)
Explore P15056 
Go to UniProtKB:  P15056
PHAROS:  P15056
GTEx:  ENSG00000157764 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP15056
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
8EN

Query on 8EN



Download:Ideal Coordinates CCD File
C [auth A],
D [auth B]
~{N}-[3-(2-acetamidoimidazo[1,2-a]pyridin-6-yl)-4-methyl-phenyl]-3-(trifluoromethyl)benzamide
C24 H19 F3 N4 O2
MRTHXFZEQBERDI-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.68 Å
  • R-Value Free:  0.218 (Depositor), 0.225 (DCC) 
  • R-Value Work:  0.178 (Depositor), 0.182 (DCC) 
  • R-Value Observed: 0.180 (Depositor) 
Space Group: P 41 21 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 93.502α = 90
b = 93.502β = 90
c = 164.703γ = 90
Software Package:
Software NamePurpose
BUSTERrefinement
PROCESSdata reduction
Aimlessdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2017-11-22
    Type: Initial release
  • Version 1.1: 2017-11-29
    Changes: Database references
  • Version 1.2: 2023-10-04
    Changes: Data collection, Database references, Refinement description